Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001087294-25-000025

Director acquired 2,027 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2025-11-03 Other acquisition 10b5-1 +68 $2.80 $190 292,663 D
Krogulski Kenneth Director 2025-11-04 Other acquisition 10b5-1 +68 $2.82 $192 292,731 D
Krogulski Kenneth Director 2025-11-05 Other acquisition 10b5-1 +68 $2.53 $172 292,799 D
Krogulski Kenneth Director 2025-11-06 Other acquisition 10b5-1 +96 $2.27 $218 292,895 D
Krogulski Kenneth Director 2025-11-07 Other acquisition 10b5-1 +96 $2.19 $210 292,991 D
Krogulski Kenneth Director 2025-11-10 Other acquisition 10b5-1 +110 $2.11 $232 293,101 D
Krogulski Kenneth Director 2025-11-11 Other acquisition 10b5-1 +110 $2.06 $227 293,211 D
Krogulski Kenneth Director 2025-11-12 Other acquisition 10b5-1 +110 $1.99 $219 293,321 D
Krogulski Kenneth Director 2025-11-13 Other acquisition 10b5-1 +110 $2.17 $239 293,431 D
Krogulski Kenneth Director 2025-11-14 Other acquisition 10b5-1 +110 $2.15 $237 293,541 D
Krogulski Kenneth Director 2025-11-17 Other acquisition 10b5-1 +117 $2.17 $254 293,658 D
Krogulski Kenneth Director 2025-11-18 Other acquisition 10b5-1 +117 $1.98 $232 293,775 D
Krogulski Kenneth Director 2025-11-19 Other acquisition 10b5-1 +117 $2.01 $235 293,892 D
Krogulski Kenneth Director 2025-11-20 Other acquisition 10b5-1 +117 $1.99 $233 294,009 D
Krogulski Kenneth Director 2025-11-21 Other acquisition 10b5-1 +117 $1.96 $229 294,126 D
Krogulski Kenneth Director 2025-11-24 Other acquisition 10b5-1 +124 $2.10 $260 294,250 D
Krogulski Kenneth Director 2025-11-25 Other acquisition 10b5-1 +124 $2.21 $274 294,374 D
Krogulski Kenneth Director 2025-11-26 Other acquisition 10b5-1 +124 $2.17 $269 294,498 D
Krogulski Kenneth Director 2025-11-28 Other acquisition 10b5-1 +124 $2.41 $299 294,622 D
Loading xslF345X05/wk-form4_1764626562.xml…